TrakCel & McKesson partner to help commercialize gene & cell therapy

By Nikita Chaurasia  | Date: 2019-09-13

TrakCel & McKesson partner to help commercialize gene & cell therapy
  • The combination of these two product suites is designed specifically for the growing number of developers that are nearing the commercial launch of gene and cell therapies.
  • The integrated platform allows the product scale-up towards market delivery including automatic product-specific workflow scheduling across multiple care team members and supply chain partners.

McKesson, a leading provider of patient access support, third-party logistic (3PL) services as well as specialty pharmacy solutions, and TrakCel, software developing firm for gene and cell therapy orchestration and supply chain tracking systems, reportedly announced a collaboration to help late-stage developers of gene and cell therapy.

The collaboration will combine both companies’ patient access services and supply chain tracking to allow a more effective path for the industry players to develop next-gen commercial therapies.

Integrating TrakCel’s personalized drug orchestration software and data tracking system with the capabilities of McKesson’s current high-touch platform for patients, as well as both the companies’ support and expertise, will give an end-to-end solution for the gene and cell therapy industry to manage the entirety of the therapeutic supply chain.

McKesson and TrakCel would start by developing a basic solution design. Both these integrated solutions will further be offered to individual company clients which would then benefit specifically from this combined solution.

The combination of these two product suites is particularly designed for the growing number of developers that are approaching commercial launch of their gene and cell therapies. The integrated platform allows the product scale-up towards market delivery.

This also involves automated scheduling of product-centric workflows across numerous care team members and supply chain partners, and a validated tracking of chain-of-identity to ensure delivery of the right drug product. These capabilities guarantee that the patient gets the right, uncompromised treatment at the correct time.

Layne Martin, VP/GM of Specialty Distribution Solutions at McKesson Life Sciences stated that the integrated system would help manufacturers and prescribers work together in a seamless manner to ensure that right patient always gets the right therapeutic product and at the correct time.

Source credit: https://www.businesswire.com/news/home/20190911005059/en/McKesson-TrakCel-Launch-Innovative-Collaboration-Support-Commercialization

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More >>

More News By Nikita Chaurasia

WeWork India rectifies glitch that revealed visitors’ personal data

WeWork India rectifies glitch that revealed visitors’ personal data

By Nikita Chaurasia

WeWork Inc., a flexible workspace solutions company, has reportedly corrected a security flaw that gave unrestrained access to the personal details and selfies of several users who visited its coworking spaces. Sandeep Hodkasia, a security consult...

China’s Great Wall Motor suspends USD 1 Bn investment plan in India

China’s Great Wall Motor suspends USD 1 Bn investment plan in India

By Nikita Chaurasia

After failing to get regulatory permits, China's Great Wall Motor has reportedly abandoned its plans to invest USD 1 billion in India and has fired all employees from its Indian facilities. The Chinese automaker had planned to penetrate the India...

Walmart to double down on frictionless optical care with Memomi buyout

Walmart to double down on frictionless optical care with Memomi buyout

By Nikita Chaurasia

Walmart Inc. is reportedly planning to acquire the augmented reality optical tech firm Memomi, reflecting the retailer’s commitment to offering frictionless and omnichannel optical care. The buyout could potentially allow Walmart to offer a fun...

Google faces antitrust lawsuit from Danish job search entity Jobindex

Google faces antitrust lawsuit from Danish job search entity Jobindex

By Nikita Chaurasia

Google LLC was reportedly hit with an antitrust case by Jobindex, a Danish online job-search rival, that took its grievance to European regulators asserting that Alphabet Inc.’s subsidiary is unjustly favoring its job-search engine. The comp...

EU vows USD 630 Mn aid to vulnerable countries amidst Ukraine-conflict

EU vows USD 630 Mn aid to vulnerable countries amidst Ukraine-conflict

By Nikita Chaurasia

The European Union has reportedly pledged USD 630 million to support weaker nations to tackle food scarcity that was made worse by Russia's assault on Ukraine. The funds include USD 368 million in aid to increase long-term sustainable food produc...